Showing results (281-290 of 367) with videos related to

Sort By:
Pageof 37
Pain Medicine (Malden, Mass.)|December 14, 2020
Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of CaliforniaMark Servis, Scott M Fishman, Mark S Wallace, et al.
Environmental Science & Technology|March 25, 2025
Low-Cost PM2.5 Sensor Performance Characteristics against Meteorological Influence in Sub-Saharan Africa: Evidence from the Air Sensor Evaluation and Training Facility for the West Africa ProjectJames Nimo, Mathias A Borketey, Emmanuel K-E Appoh, et al.
Leukemia|March 19, 2011
Recurrent DNMT3A mutations in patients with myelodysplastic syndromesM J Walter, L Ding, D Shen, et al.
JCO Oncology Practice|January 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102Wael Saber, Aasthaa Bansal, Lily Li, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Transplantation and Cellular Therapy|August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell TransplantationZiheng Xu, Jaebok Choi, Matthew Cooper, et al.
Frontiers in Aging Neuroscience|May 6, 2014
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyJane S Paulsen, Jeffrey D Long, Hans J Johnson, et al.
Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Pageof 37